UPDATES
Publication- Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells
PREDICT-Meso Co-I Daniel J. Murphy co-authoured a paper accepted for publication in Cell Death and Disease, with Olivier E. Pardo and Yakinthi Chrisochoidou at Imperial. This work was carried out as part of WP4- Target Drug Validation Abstract Mesothelioma is an aggressive cancer of the...
Publication- Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance
click here for link to full text
Publication- Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma
click here for link to full text
PREDICT-Meso pre-clinical models school
Pre-clinical models school
iMig 2023
PREDICT-Meso at iMig 2023
PREDICT-MESO NEWSLETTER #2 JULY 2023
Click here to access PREDICT-Meso Newsletter #2 July23
Meso-ORIGINS UPDATE MAY 2023
Meso-ORIGINS has been open for 11 months now and things are going well. We now have 14 Health Boards/Trusts open, with 15 hospitals taking part across these 14 sites. NHS Greater Glasgow and Clyde (NHSGGC)- Queen Elizabeth University Hospital; Glasgow Royal Infirmary; Gartnavel General Hospital...
Applications for the Mesothelioma UK 2023 funding grant are now open
Up to £40,000 of grant funding is available
PREDICT-Meso Newsletter – April 2023
Click here for access to the first PREDICT-Meso Newsletter
PREDICT-Meso abstracts accepted for iMig 2023
Click here to find out more about our accepted abstracts
EVENTS
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.